Cancer research, long protected, feels ‘devastating’ effects under Trump

Taking stock of the drug industry, from the lab to the medicine chest

March 24, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Mark Schiefelbein/AP STAT+ | Cancer research, long protected, feels 'devastating' effects under Trump Cancer research has had bipartisan support. But Trump administration cuts threaten to reverse progress of recent years, experts say. By Angus Chen Lawmakers are pushing the HALT Fentanyl Act as the solution to the overdose crisis. Experts warn it will fall short Bill in Congress targets fentanyl-related substances, but illegally manufactured fentanyl is far more prevalent and kills more people. By Samanta Habashy — Medill News Service STAT+ | Opinion: Philanthropy can help create a healthier biotech ecosystem There is potential for foundations to more strongly bolster competition in the market for biotech — in both venture and social justice philanthropy. By Brian Stanley and Michael Nguyen-Mason

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser